These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 4065159)
1. Uremic neuropathy: clinical and neurophysiological investigation of dialysis patients using different chemical membranes. Violante F; Lorenzi S; Fusello M Eur Neurol; 1985; 24(6):398-404. PubMed ID: 4065159 [TBL] [Abstract][Full Text] [Related]
2. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia. Avram MM; Feinfeld DA; Huatuco AH N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786 [TBL] [Abstract][Full Text] [Related]
3. Uremic neuropathy: correlations between electroneurographic parameters and serum levels of parathyroid hormone and aluminum. Aiello I; Serra G; Gilli P; Rosati G; Manca M; De Bastiani P; Fagioli F Eur Neurol; 1982; 21(6):396-400. PubMed ID: 6293832 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of dialysis with cuprophan versus polyacrylonitrile membranes on plasma immunoreactive parathyroid hormone levels in patients on chronic hemodialysis. Gueris J; Fournier A; Sebert JL; De Fremont JF; Ferriere C; Covoet B; Quichaud J Calcif Tissue Res; 1977 May; 22 Suppl():434-8. PubMed ID: 912564 [No Abstract] [Full Text] [Related]
5. Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients. Schaefer K; Offermann G; von Herrath D; Schröter R; Stölzel R; Arntz HR Clin Nephrol; 1980 Aug; 14(2):81-8. PubMed ID: 7408260 [TBL] [Abstract][Full Text] [Related]
6. Effect of hemodialysis membrane type on parathyroid hormone removal. Kudlac H; Fielding AM; Williams AJ Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210 [TBL] [Abstract][Full Text] [Related]
7. [Radiological, biochemical and clinical aspects of uremic osteopathy in patients with long term dialysis]. Frey FJ; Jonutis AJ; Bergstein Z; Hodler J; Flury W Schweiz Med Wochenschr; 1976 Oct; 106(42):1438-46. PubMed ID: 1006271 [TBL] [Abstract][Full Text] [Related]
8. Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients. Ohya M; Negi S; Sakaguchi T; Koiwa F; Ando R; Komatsu Y; Shinoda T; Inaguma D; Joki N; Yamaka T; Ikeda M; Shigematsu T J Clin Endocrinol Metab; 2014 Oct; 99(10):3873-8. PubMed ID: 24937533 [TBL] [Abstract][Full Text] [Related]
9. [Velocity of maximal motor nerve conduction in polyneuropathies of uremic patients subjected to various types of hemodialysis for varying periods of time: values and limitations]. Savazzi GM; Arisi L; Bignardi L; Rossi E; Cambi V; Allegri L Riv Neurol; 1976; 46(1):25-35. PubMed ID: 1013604 [No Abstract] [Full Text] [Related]
10. The effects of hemodialysis with different membranes on middle molecules and uremic neuropathy. Djukanović LJ; Mimić-Oka JI; Potić JB Int J Artif Organs; 1989 Jan; 12(1):11-9. PubMed ID: 2538398 [TBL] [Abstract][Full Text] [Related]
11. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Mallamaci F; Zoccali C; Ciccarelli M; Briggs JD Clin Nephrol; 1986 Apr; 25(4):175-80. PubMed ID: 3516480 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of PTH, Mg, Ca, inorganic phosphate and alkaline phosphatases in uraemic patients on differentiated Mg dialysis. Gonella M; Moriconi L; Betti G; Bonaguidi F; Buzzigoli G; Bartolini V; Mariani G Proc Eur Dial Transplant Assoc; 1980; 17():362-6. PubMed ID: 7243793 [TBL] [Abstract][Full Text] [Related]
13. Nervous system complications in uremia. Fraser CL; Arieff AI Ann Intern Med; 1988 Jul; 109(2):143-53. PubMed ID: 2837930 [TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
15. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry. Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528 [TBL] [Abstract][Full Text] [Related]
16. Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood. Schaefer K; von Herrath D; Gullberg CA; Asmus G; Hüfler M; Offermann G; Cremer H; Heuck CC; Ritz E Artif Organs; 1978 Nov; 2(4):386-94. PubMed ID: 743012 [TBL] [Abstract][Full Text] [Related]
17. Gastric acid secretion, calcitonin and secondary hyperparathyroidism in uremic patients undergoing regular dialysis therapy (RDT). Antonucci F; Vezzadini P; Cecchettin M; Bonora G; Adami A; Compiano U; Feder G Int J Artif Organs; 1978 Nov; 1(6):260-5. PubMed ID: 738794 [TBL] [Abstract][Full Text] [Related]
18. The influence of glomerular filtration rate on uremic polyneuropathy. Savazzi GM; Migone L; Cambi V Clin Nephrol; 1980 Feb; 13(2):64-72. PubMed ID: 6244910 [No Abstract] [Full Text] [Related]
19. Uremic neuropathy. Monitoring of transketolase activity inhibition in a child. McVicar M; Gauthier B; Goodman CT Am J Dis Child; 1973 Feb; 125(2):263-5. PubMed ID: 4265477 [No Abstract] [Full Text] [Related]
20. Sympathetic skin response in hemodialysis patients: correlation with nerve conduction studies and adequacy of dialysis. Robles NR; Solis M; Albarran L; Esparrago JF; Roncero F; Sanchez-Casado E Nephron; 1999; 82(1):12-6. PubMed ID: 10224478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]